Significant Options Trading on Thursday: HLF, ROOT, CORZ
Root Inc Options Activity: Root Inc (ROOT) experienced significant options trading with 1,802 contracts, equating to about 180,200 underlying shares, particularly notable for the $115 strike call option expiring January 16, 2026, which saw 802 contracts traded.
Core Scientific Inc Options Activity: Core Scientific Inc (CORZ) had a high options trading volume of 69,675 contracts, representing approximately 7.0 million underlying shares, with a focus on the $14 strike put option expiring December 19, 2025, which had 34,263 contracts traded.
Trading Volume Comparison: The options trading volumes for both ROOT and CORZ were substantial, with ROOT's volume at 54.8% of its average daily trading and CORZ at 54.2% of its average daily trading volume over the past month.
Further Information: For more details on available expirations for HLF, ROOT, or CORZ options, StockOptionsChannel.com provides additional resources.
Trade with 70% Backtested Accuracy
Analyst Views on CORZ
About CORZ
About the author

- Stake Sale Overview: On February 13, 2026, Helix Partners Management LP disclosed in an SEC filing the sale of its entire 200,000-share stake in SLM Corporation for approximately $5.54 million, indicating a cautious outlook on the company's future performance.
- SLM Financial Status: As of February 12, 2026, SLM shares were priced at $24.76, reflecting a 14.6% decline over the past year, and underperforming the S&P 500 by 27.5 percentage points during the same period, raising concerns about its growth potential.
- Investor Considerations: Despite SLM achieving a GAAP diluted EPS of $3.46 and a net interest margin of 5.21% in 2025, the delinquency rate rose to 4.0%, with guidance for net charge-offs in 2026 projected between $345 million and $385 million, signaling a trend of credit normalization.
- Future Outlook: Helix Partners' decision to trim its position may reflect a cautious stance on SLM's growth prospects, even as the company remains profitable and well-capitalized, prompting investors to focus on capital returns and credit metrics to assess the viability of holding the stock.
- Share Acquisition: Helix Partners Management increased its stake in Core Scientific by 350,000 shares in Q4 2026, with an estimated transaction value of $6.10 million, indicating strong confidence in the company despite a $12.65 million decline in overall position value due to stock price fluctuations.
- Asset Allocation Shift: Core Scientific now represents 27.41% of Helix Partners' assets under management, becoming its largest holding, reflecting management's focus on digital asset mining and blockchain infrastructure services, which may influence future investment decisions.
- Financial Performance Insights: Core Scientific generated $81.1 million in revenue in Q3 2023, showing growth in high-density colocation revenue from $10.3 million to $15.0 million, despite a year-over-year decline in total revenue, highlighting the potential of its business transformation.
- Strategic Transition Signals: The company is pivoting its facilities towards high-density colocation tied to AI workloads, and while facing a net loss of $146.7 million, its liquidity of $694.8 million provides a buffer for future growth, prompting investors to monitor execution outcomes.
- Stake Increase Details: Helix Partners Management increased its stake in Core Scientific by 350,000 shares in Q4, with an estimated trade value of $6.10 million; however, the reported value of the Core Scientific position fell by $12.65 million, indicating the impact of market volatility on the portfolio.
- Ownership Analysis: Post-trade, Helix Partners holds 5.6 million shares of Core Scientific valued at $81.54 million, which constitutes 27.41% of its reportable AUM, reflecting strong conviction from management regarding the company's future prospects.
- Financial Performance Overview: Core Scientific generated $81.1 million in revenue during Q3, with high-density colocation revenue rising from $10.3 million to $15.0 million year-over-year, showcasing growth potential in the digital asset mining sector despite a decline in total revenue.
- Future Outlook and Risks: Management is pivoting facilities towards high-density colocation tied to AI workloads, and despite a net loss of $146.7 million, liquidity remains robust at $694.8 million, prompting investors to monitor colocation revenue growth and capital expenditure closely.
- Significant Revenue Growth: CoreWeave's revenue skyrocketed from $16 million in 2022 to $1.9 billion in 2024, with projections of reaching $5.1 billion in 2025, showcasing its strong growth potential in the AI market.
- Data Center Expansion: The company expanded from three data centers at the end of 2022 to 33, leveraging dedicated GPUs to process AI tasks 35 times faster and 80% cheaper than larger cloud platforms, significantly enhancing its competitive edge.
- Capital Strategy: CoreWeave secured additional financing by leveraging GPUs as collateral and invested $100 million in Nvidia's H100 data center GPUs in 2022, further driving its infrastructure expansion.
- Optimistic Future Outlook: Despite risks from a 70% revenue dependency on Microsoft and potential debt increases, analysts expect its market cap to double to $98 billion by 2027, reflecting confidence in its long-term growth trajectory.
- Share Sale Overview: Pier Capital sold all 504,958 shares of Core Scientific in Q4 for approximately $9.06 million, indicating a risk-averse strategy towards the company amid declining performance.
- Declining Financial Performance: Core Scientific's Q3 revenue fell from $95.4 million to $81.1 million, primarily due to a 55% year-over-year drop in Bitcoin mined, negatively impacting profitability and highlighting operational challenges.
- Capital Expenditures and Liquidity: While capital expenditures reached $244.5 million for infrastructure buildouts, liquidity remains substantial at around $695 million; however, adjusted EBITDA showed a loss of $2.4 million, reflecting financial strain during the transition.
- Strategic Transformation Challenges: Core Scientific is pivoting from volatile self-mining to high-density colocation services, with future success hinging on executing this capital-intensive transformation rather than relying solely on cryptocurrency price fluctuations.
- Price Range Analysis: CORZ's 52-week low is $6.20 per share, while the high is $23.63, with the last trade at $14.81, indicating significant volatility over the past year that may influence investor decisions.
- Market Trend Insight: The current stock price is at 62.6% of the 52-week high, suggesting that despite a recent decline, there remains potential for recovery, which could attract investors looking for rebound opportunities.
- Technical Indicator Alert: CORZ's stock price has fallen below its 200-day moving average, typically viewed as a technical sell signal, potentially leading to further downward pressure in the short term, necessitating careful risk assessment by investors.
- Investor Sentiment Impact: Although the current stock price is below the 200-day moving average, market sentiment may be influenced by the broader economic environment and industry dynamics, prompting investors to stay informed on relevant market news for informed decision-making.










